Allison E. Drew

949 total citations
22 papers, 661 citations indexed

About

Allison E. Drew is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Allison E. Drew has authored 22 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Allison E. Drew's work include Cancer-related gene regulation (8 papers), Epigenetics and DNA Methylation (5 papers) and Nicotinic Acetylcholine Receptors Study (4 papers). Allison E. Drew is often cited by papers focused on Cancer-related gene regulation (8 papers), Epigenetics and DNA Methylation (5 papers) and Nicotinic Acetylcholine Receptors Study (4 papers). Allison E. Drew collaborates with scholars based in United States. Allison E. Drew's co-authors include Linda L. Werling, Charles F. Williams, Scott Ribich, Robert A. Copeland, J. Joshua Smith, Richard Chesworth, Melissa J. Merrick, Rosemary J. Smith, Heike Keilhack and Elayne Chan-Penebre and has published in prestigious journals such as Blood, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Allison E. Drew

22 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allison E. Drew United States 11 444 111 94 79 77 22 661
Emily E. Hare United States 7 433 1.0× 31 0.3× 133 1.4× 21 0.3× 121 1.6× 9 768
Yasuo Mukai Japan 12 146 0.3× 51 0.5× 38 0.4× 15 0.2× 14 0.2× 20 430
Louise M. McKenzie Australia 11 140 0.3× 28 0.3× 47 0.5× 11 0.1× 44 0.6× 15 443
John M. Peters United States 9 488 1.1× 118 1.1× 12 0.1× 29 0.4× 42 0.5× 12 754
Virginie Vervoort United States 10 256 0.6× 176 1.6× 11 0.1× 29 0.4× 317 4.1× 12 846
M. D'Antonio Italy 16 76 0.2× 51 0.5× 17 0.2× 56 0.7× 27 0.4× 32 633
Massimiliano Delpero Italy 14 159 0.4× 97 0.9× 7 0.1× 20 0.3× 134 1.7× 39 580
Sandy Goodburn United Kingdom 9 294 0.7× 15 0.1× 36 0.4× 181 2.3× 78 1.0× 12 650
Neetha Nanoth Vellichirammal United States 15 296 0.7× 91 0.8× 5 0.1× 83 1.1× 81 1.1× 32 638
Jesper Brohede Sweden 10 190 0.4× 30 0.3× 14 0.1× 12 0.2× 76 1.0× 20 416

Countries citing papers authored by Allison E. Drew

Since Specialization
Citations

This map shows the geographic impact of Allison E. Drew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison E. Drew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison E. Drew more than expected).

Fields of papers citing papers by Allison E. Drew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison E. Drew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison E. Drew. The network helps show where Allison E. Drew may publish in the future.

Co-authorship network of co-authors of Allison E. Drew

This figure shows the co-authorship network connecting the top 25 collaborators of Allison E. Drew. A scholar is included among the top collaborators of Allison E. Drew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison E. Drew. Allison E. Drew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drew, Allison E., et al.. (2018). Abstract 807: Mechanism of action of synergistic activity of EZH2 inhibition and IMiDs in preclinical multiple myeloma models. Cancer Research. 78(13_Supplement). 807–807. 1 indexed citations
2.
Hood, Tami, et al.. (2018). Abstract 808: Opportunity for therapeutic expansion in mantle cell lymphoma: Tazemetostat combination synergy status in preclinical MCL models. Cancer Research. 78(13_Supplement). 808–808. 2 indexed citations
3.
Drew, Allison E., Trupti Lingaraj, Natalie M. Warholic, et al.. (2017). EZH2 Inhibition by Tazemetostat Results in Altered Dependency on B-cell Activation Signaling in DLBCL. Molecular Cancer Therapeutics. 16(11). 2586–2597. 52 indexed citations
4.
Chan-Penebre, Elayne, Kelli Armstrong, Allison E. Drew, et al.. (2017). Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models. Molecular Cancer Therapeutics. 16(5). 850–860. 127 indexed citations
5.
Drew, Allison E., John E. Campbell, Cuyue Tang, et al.. (2017). Abstract 5060: Activity of the EZH2 inhibitor tazemetostat as a monotherapy and in combination with multiple myeloma therapies in preclinical models. Cancer Research. 77(13_Supplement). 5060–5060. 3 indexed citations
6.
Mitchell, Lorna H., Allison E. Drew, Scott Ribich, et al.. (2015). Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 Tool Compound. ACS Medicinal Chemistry Letters. 6(6). 655–659. 95 indexed citations
7.
Knutson, Sarah K., Allison E. Drew, Christopher Plescia, et al.. (2015). Abstract C87: EZH2 inhibition leads to decreased proliferation in SMARCA4-deleted ovarian cancer cell lines. Molecular Cancer Therapeutics. 14(12_Supplement_2). C87–C87. 3 indexed citations
8.
Boriack‐Sjodin, P. Ann, Lei Jin, Suzanne L. Jacques, et al.. (2015). Structural Insights into Ternary Complex Formation of Human CARM1 with Various Substrates. ACS Chemical Biology. 11(3). 763–771. 32 indexed citations
9.
Boriack-Sjodin, Ann, Lei Jin, Suzanne L. Jacques, et al.. (2015). Abstract 2437: Crystal structures of CARM1 bound to sinefungin and diverse peptide substrates. Cancer Research. 75(15_Supplement). 2437–2437. 1 indexed citations
10.
Wilcoxen, Keith, Rachael Brake, Yohannes Teffera, et al.. (2012). Abstract 1795: Characterization of a novel series of potent, selective inhibitors of wild type and mutant/fusion anaplastic lymphoma kinase. Cancer Research. 72(8_Supplement). 1795–1795. 10 indexed citations
11.
Lewis, Richard T., Christiane Bode, Deborah M. Choquette, et al.. (2012). The Discovery and Optimization of a Novel Class of Potent, Selective, and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with Potential Utility for the Treatment of Cancer. Journal of Medicinal Chemistry. 55(14). 6523–6540. 38 indexed citations
12.
Drew, Allison E., Violeta Yu, Paul S. Andrews, et al.. (2011). Comparison of 2 Cell-Based Phosphoprotein Assays to Support Screening and Development of an ALK Inhibitor. SLAS DISCOVERY. 16(2). 164–173. 5 indexed citations
14.
Drew, Allison E. & George Roderick. (2005). Insect Biodiversity on Plant Hybrids Within the Hawaiian Silversword Alliance (Asteraceae: Heliantheae-Madiinae). Environmental Entomology. 34(5). 1095–1108. 8 indexed citations
15.
Drew, Allison E. & George Roderick. (2005). Insect Biodiversity on Plant Hybrids Within the Hawaiian Silversword Alliance (Asteraceae: Heliantheae-Madiinae). Environmental Entomology. 34(5). 1095–1108. 8 indexed citations
16.
Drew, Allison E. & Linda L. Werling. (2003). Nicotinic receptor-mediated regulation of the dopamine transporter in rat prefrontocortical slices following chronic in vivo administration of nicotine. Schizophrenia Research. 65(1). 47–55. 20 indexed citations
17.
Drew, Allison E. & Linda L. Werling. (2001). Protein kinase C regulation of dopamine transporter initiated by nicotinic receptor activation in slices of rat prefrontal cortex. Journal of Neurochemistry. 77(3). 839–848. 22 indexed citations
18.
Drew, Allison E., et al.. (2000). Nicotinic receptor-mediated regulation of dopamine transporter activity in rat prefrontal cortex. Synapse. 38(1). 10–16. 73 indexed citations
19.
Drew, Allison E., et al.. (2000). Nicotinic receptor‐mediated regulation of dopamine transporter activity in rat prefrontal cortex. Synapse. 38(1). 10–16. 4 indexed citations
20.
Smith, Rosemary J., et al.. (2000). Altitudinal Variation in Body Size and Population Density of <I>Nicrophorus investigator</I> (Coleoptera: Silphidae). Environmental Entomology. 29(2). 290–298. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026